A taste of its own medicine?

BySHLOMO MAITAL
February 21, 2017 16:48

Teva Pharmaceuticals, Israel’s biggest company, has seen its share price halved as generics eat at its profits, and leveraged buyouts have left it burdened with huge debts.




Erez Vigodman

Erez Vigodman. (photo credit:WWW.TEVAPHARM.COM)

TEVA PHARMACEUTICAL Industries is in trouble. By definition, when the share price of Israel’s oldest and biggest global company plunges 50 percent in one year, it is time to worry and investigate.

Teva’s stock-price chart looks like the Himalayas or the Kingda Ka roller coaster in Jackson, New Jersey, the world’s tallest.

Read More...

Related Content
Begin Netanyahu
June 26, 2017
Has it really been 40 years since Israel's political revolution?

By AMOTZ ASA-EL